MAIA Biotechnology, Inc.
Pharmaceutical company · Chicago, Illinois, United States · NYSE: MAIA
MAIA Biotechnology, Inc. is a pharmaceutical company headquartered in Chicago, Illinois, United States. Its shares trade on NYSE under the ticker MAIA. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $770,168 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2026.
MAIA Biotechnology at a glance
What does MAIA Biotechnology do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $770,168 in total (2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $1.5 million sold (2026).
Frequently asked questions about MAIA Biotechnology
Where is MAIA Biotechnology headquartered?
MAIA Biotechnology, Inc. is headquartered in Chicago, Illinois, United States.
What does MAIA Biotechnology do?
MAIA Biotechnology, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is MAIA Biotechnology a public company?
Yes. MAIA Biotechnology, Inc. trades on NYSE under the ticker MAIA.
Similar companies
- Xeris Pharmaceuticals IncChicago, Illinois, United States
- Exicure, Inc.Chicago, Illinois, United States
- Bright Minds Biosciences Inc.Chicago, Illinois, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.